Reports and Data

Mycoplasma Testing Market to Deliver Greater Revenues During the Forecast Period Until 2027: Thermo Fisher Scientific, Lonza Group Ltd., Merck KGaA

An extensive study of the product application and services conducted by subject matter experts assessing the Mycoplasma Testing Market will help product owners to make a wise decision.


New York, NY -- (SBWIRE) -- 11/30/2020 -- According to the current analysis of Reports and Data, the global Mycoplasma Testing market size was valued at USD 609.39 million in 2019 and is expected to reach USD 1.59 billion by year 2027, at a CAGR of 12.6%. Mycoplasma is the smallest known species of bacteria, that has developed due to the de-generative evolution from Gram-positive bacteria. Mycoplasma bacterial cell has missing cell wall and can either be saprotrophic or parasitic. In spite of there being nearly 200 different types of mycoplasma bacteria, a majority of them are harmless. Only 5 out of 200 cause severe infections in humans.

Different mycoplasma species cause different diseases in the human body. For instance, Mycoplasma pneumonia affects the throat and lungs, while Mycoplasma genitalium is related to urethra infection. Mycoplasma testing is used to examine present or past mycoplasma infection in patients. Mycoplasma microbes can exist as healthy flora in the patient's genitourinary tract, throat, or respiratory tract. Moreover, due to absence of cell wall, the mycoplasma bacterial cells are immune to various common antibiotics. Mycoplasma testing plays an important role in cell culture and every step of product development requires this testing, including cell banks, viral seed stocks, and final products.

Get a Sample of the Report @

The mycoplasma testing market growth is fueled by significant research and development activities in academia and bio-pharmaceutical industry, increasing occurance of mycoplasma infections, and cell culture contamination. Mycoplasma can rapidly spread through droplets during cell culture and are hard to detect under a microscope. Therefore, they need specific tests to be identified. Growing expenditure in the healthcare sector by leading market players to improve customer satisfaction and achieve technological advancements is expected to stimulate the global market for mycoplasma testing.

Mycoplasma testing market is also driven by the increased adoption of mycoplasma testing in the microbiology sector, growing incidence of water pollution-related infections, increased investment in the healthcare industry through public and private sectors, and higher awareness about mycoplasma bacterial infections. However, limited awareness about mycoplasma infection among patients and clinicians, and challenges related to its detection are expected to hinder the market growth.

Mycoplasma testing market is growing at a remarkable CAGR of 13% in Asia Pacific, followed by North America and Europe, with 12.8 % and 12.5% CAGR respectively. Increasing government support, coupled with high investments in R&D, are major factors driving the market growth in these regions.

Key participants in the mycoplasma testing market include:

- Thermo Fisher Scientific Inc.
- Lonza Group Ltd.
- Merck KGaA
- Roche Diagnostics
- American Type Culture Collection
- Bionique Testing Laboratories, Inc.
- InvivoGen
- PromoCell GmbH
- Norgen Biotek Corp.
- GenBio
- Meridian Bioscience, Inc.
- Savyon Diagnostics

Mycoplasma Testing Market: Segmentation

For the purpose of this report, Reports and Data has segmented the mycoplasma testing market on the basis of product type, technology type, application type, end use, and region:
Product Type (Revenue, USD Million; 2017–2027)
- Instruments
- Kits & Reagents
o PCR Assay
o Nucleic Acid Detection
o Elimination Kits & Reagent
o Stains
o Standards & Controls
o Others
- Services
- Others

Technology Type (Revenue, USD Million; 2017–2027)
- Direct Assay
- Indirect Assay
- DNA Staining
- Microbial Culture Techniques
- Enzymatic Methods
- Others

Application Type (Revenue, USD Million; 2017–2027)
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Others

End Use (Revenue, USD Million; 2017–2027)
- Pharmaceutical Companies
- Cell Banks
- Others

Access Full Report Description, TOC, Table of Figure, Chart, etc. @

Regional Outlook (Revenue in USD Million; 2017–2027)
- North America
o U.S.
o Canada
- Europe
o Germany
o France
o UK
o Spain
o Italy
o Rest of the Europe
- Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
- Middle East & Africa
- Latin America
o Brazil

Get a Sample of the Report @

Thank you for reading our report. Please get in touch with us for further queries and our team will ensure you get the report according to your needs.

Similar Reports –
1. Biomaterials Market Size, Demand & Analysis, Trends, By Type, By Application, Forecasts To 2027

2. Biochip Market By Type, By Connector Type, By Industry Vertical, By Region, Segment Forecasts To 2027

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
Reports and Data | Web: